Clinical Course, Neurobiology and Therapeutic Approaches to Treatment Resistant Schizophrenia. Toward an Integrated View

Despite considerable psychotherapeutic advancement since the discovery of chlorpromazine, almost one third of patients with schizophrenia remain resistant to dopamine-blocking antipsychotics, and continue to be exposed to unwanted and often disabling side effects, but little if any clinical benefit....

Full description

Saved in:
Bibliographic Details
Published in:Front Psychiatry
Main Authors: Leung, Cheryl Cheuk-Yan, Gadelrab, Romayne, Ntephe, Chukwuma Uchenna, McGuire, Philip K., Demjaha, Arsime
Format: Artigo
Language:Inglês
Published: Frontiers Media S.A. 2019
Subjects:
Psychiatry
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6735262/
https://ncbi.nlm.nih.gov/pubmed/31551822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fpsyt.2019.00601
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items